Antidiabetic activity of the mangrove speciesCeriops decandrain alloxan‐induced diabetic rats
- 25 May 2010
- journal article
- Published by Wiley in Journal of Diabetes
- Vol. 2 (2) , 97-103
Abstract
Background: Diabetes is a series of disorders characterized by increased fasting and postprandial glucose concentration and insulin deficiency and/or decreased insulin action. Although there are a number of commercially available drugs for the treatment of diabetes, their long‐term use may cause unwanted side effects. Consequently, many studies are underway to find natural remedies that can effectively reduce the intensity of diabetes. The aim of the present study was to evaluate the antidiabetic activity of the mangrove speciesCeriops decandra.Methods: The effects of daily oral administration of an ethanolic extract from the leaves ofC. decandra(30, 60, 120 mg/kg) for 30 days on blood glucose, hemoglobin (Hb), HbA1c, liver glycogen and some carbohydrate metabolic enzymes were evaluated in normal and alloxan‐induced diabetic rats. The effects of these extracts were compared with the effect of 30‐days treatment with 0.1 mg/kg, p.o., glibenclamide, a commercially available drug commonly used in the treatment of diabetes.Results: Oral administration of 120 mg/kg extract modulated all the parameters evaluated to levels seen in control rats. The effects of 120 mg/kg extract were comparable to those of glibenclamide.Conclusion: The extract of the mangrove plantC. decandraexhibited promising antidiabetic activity and could be considered for further evaluation in clinical studies and drug development.Keywords
This publication has 22 references indexed in Scilit:
- Evaluation of antidiabetic, antioxidant and vasoprotective effects of Posidonia oceanica extractJournal of Ethnopharmacology, 2008
- Antidiabetic activity of Boerhaavia diffusa L.: effect on hepatic key enzymes in experimental diabetesJournal of Ethnopharmacology, 2004
- Biology of mangroves and mangrove Ecosystems2001
- Regulation of metabolic pathways in liver and kidney during experimental diabetes: Effects of antidiabetic compoundsIndian Journal of Clinical Biochemistry, 1998
- NIDDM — the devastating diseaseDiabetes Research and Clinical Practice, 1995
- Alloxan: history and mechanism of actionDiabetologia, 1988
- Fructose-1,6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non fermenting yeastsArchives of Microbiology, 1971
- Pathological occurrence of glucose-6-phosphatase in serum in liver diseasesClinica Chimica Acta, 1959
- Multiple Range Tests for Correlated and Heteroscedastic MeansBiometrics, 1957
- The Hexokinase and Phosphoglucoisomerase Activities of Aortic and Pulmonary Artery Tissue in Individuals of Various AgesJournal of Gerontology, 1957